A detailed history of State Street Corp transactions in Compugen LTD stock. As of the latest transaction made, State Street Corp holds 167,107 shares of CGEN stock, worth $242,305. This represents 0.0% of its overall portfolio holdings.

Number of Shares
167,107
Previous 164,737 1.44%
Holding current value
$242,305
Previous $276,000 9.42%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.56 - $2.1 $3,697 - $4,977
2,370 Added 1.44%
167,107 $302,000
Q2 2024

Aug 14, 2024

BUY
$1.68 - $2.52 $4,500 - $6,751
2,679 Added 1.65%
164,737 $276,000
Q1 2024

May 15, 2024

SELL
$1.75 - $2.95 $5,213 - $8,788
-2,979 Reduced 1.81%
162,058 $418,000
Q4 2023

Feb 14, 2024

BUY
$0.53 - $2.0 $1,460 - $5,510
2,755 Added 1.7%
165,037 $326,000
Q3 2023

Nov 14, 2023

BUY
$0.88 - $1.31 $3,160 - $4,704
3,591 Added 2.26%
162,282 $150,000
Q2 2023

Aug 14, 2023

BUY
$0.57 - $1.38 $1,666 - $4,033
2,923 Added 1.88%
158,691 $180,000
Q1 2023

May 15, 2023

BUY
$0.68 - $1.11 $4,514 - $7,369
6,639 Added 4.45%
155,768 $109,000
Q4 2022

Feb 14, 2023

BUY
$0.58 - $1.2 $5,283 - $10,932
9,110 Added 6.51%
149,129 $107,000
Q3 2022

Nov 15, 2022

BUY
$0.66 - $2.32 $1,766 - $6,210
2,677 Added 1.95%
140,019 $92,000
Q2 2022

Aug 15, 2022

SELL
$1.57 - $3.33 $965,813 - $2.05 Million
-615,168 Reduced 81.75%
137,342 $254,000
Q1 2022

May 16, 2022

BUY
$2.76 - $4.64 $188,612 - $317,088
68,338 Added 9.99%
752,510 $2.42 Million
Q4 2021

Feb 14, 2022

SELL
$4.09 - $7.16 $4 - $7
-1 Reduced -0.0%
684,172 $2.94 Million
Q3 2021

Nov 15, 2021

BUY
$5.8 - $8.02 $166,906 - $230,791
28,777 Added 4.39%
684,173 $4.09 Million
Q2 2021

Aug 16, 2021

BUY
$6.87 - $9.16 $501,578 - $668,771
73,010 Added 12.54%
655,396 $5.43 Million
Q1 2021

May 17, 2021

BUY
$7.67 - $13.77 $150,332 - $269,892
19,600 Added 3.48%
582,386 $5 Million
Q4 2020

Feb 16, 2021

BUY
$12.07 - $17.95 $694,700 - $1.03 Million
57,556 Added 11.39%
562,786 $6.82 Million
Q3 2020

Nov 10, 2020

BUY
$14.16 - $19.45 $368,174 - $505,719
26,001 Added 5.43%
505,230 $8.21 Million
Q2 2020

Aug 14, 2020

BUY
$6.97 - $17.12 $3.2 Million - $7.86 Million
459,206 Added 2293.39%
479,229 $7.2 Million
Q1 2020

May 11, 2020

BUY
$5.79 - $11.83 $115,933 - $236,872
20,023 New
20,023 $145,000

Others Institutions Holding CGEN

About COMPUGEN LTD


  • Ticker CGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,624,600
  • Market Cap $126M
  • Description
  • Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...
More about CGEN
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.